{
  "main_header": {
    "sid": 982753,
    "name": "Ambalal Sarabhai",
    "stock_name": "Ambalal Sarabhai",
    "full_name": "Ambalal Sarabhai Enterprises Ltd",
    "name_url": "stocks-analysis/ambalal-sarabhai",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "26.20",
    "chg": -0.27,
    "chgp": "-1.02%",
    "dir": -1,
    "prev_price": "26.47",
    "mcapval": "193.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 500009,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE432A01017",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "56.08 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/ambalal-sarabhai-982753-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 120,
    "sid": "982753",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/ambalal-sarabhai-enterprises-982753"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "30-Mar-2026",
      "details": "Intimation of Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "16-Feb-2026",
      "details": "We here by submit Newspaper publication under Regulation 30 and 47 of SEBI (LODR) Regulations 2015. Kindly take the same on your records.",
      "source": "BSE"
    },
    {
      "caption": "Results - Financial Results For The Quarter And Nine Months Ended On 31.12.2025",
      "datetime": "12-Feb-2026",
      "details": "We hereby submit financial Result (Standalone and Consolidated) for the quarter and nine months ended 31.12.2025 along with Limited Review Report of Auditors thereon. Kindly take the same on your records.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News